Valtecne S.p.A. (BIT:VLT)

Market Cap	43.68M
Revenue (ttm)	31.58M
Net Income (ttm)	3.42M
Shares Out	6.11M
EPS (ttm)	0.56
PE Ratio	12.78
Forward PE	12.77
Dividend	0.10 (1.42%)
Ex-Dividend Date	May 12, 2025

Volume	8,100
Average Volume	795
Open	7.10
Previous Close	7.05
Day's Range	7.00 - 7.35
52-Week Range	5.45 - 7.15
Beta	0.17
RSI	67.41
Earnings Date	Sep 23, 2025

About Ligand Pharmaceuticals

Valtecne S.p.A. manufactures and sells precision mechanical components in Italy. The company engages in the CNC machining of high precision medical and surgical instruments, such as hip surgery components, knee instruments and implants, spine surgery instruments, and shoulder replacement parts; and CNC machining of mechanical components, including turbine blades, power reducers, and mechanical parts for energy, power transmission, automotive, and other sectors. The company was founded in 1983 and is based in Berbenno di Valtellina, Italy.

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• Founded: 1983
• Employees: 146
• Stock Exchange: Borsa Italiana
• Ticker Symbol: VLT

Financial Performance

In 2024, Valtecne's revenue was 31.58 million, a decrease of -0.28% compared to the previous year's 31.67 million. Earnings were 3.42 million, an increase of 7.43%.